Of interest, our data suggested that the level of TRIM47 was largely raised in glioblastoma multiforme (GBM) and lower-grade glioma (LGG) tissues after GEPIA database analysis (Figure 1(a)). This evidence concerns the gene TRIM47 and central nervous system cancer.